• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SINGLE PORT; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SINGLE PORT; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383520
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/23/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.E1.Address information was not provided, therefore, (b)(6) was used as a place holder.
 
Event or Problem Description
It was reported that bd nexiva hf single port leaks at the septum.The following information was provided by the initial reporter: nexiva leaking from septum where the needle comes out.It has happened 4 times so far.(b)(6) could you please provide a further description of the issue? blood was leaking out of the grey septum where the needle comes out to safety.This happened 4 different times with different size gage and length catheters.When was this defect observed? during or before use? during use.What was the impact to the patient? had to get a new line.Any adverse event or serious injury reported to patient or healthcare professional? if yes, please provide the details.No.Any sample or photo available for investigation? if yes, are you able to provide the address of the facility for us to ship the return label? no available sample.What was the fluid at use? n/a, blood leaking upon placement.
 
Additional Manufacturer Narrative
Investigation results: a device history record review was completed by our quality engineer team for provided material number 383520 and lot number 2312135.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.As a sample was unavailable for return, a thorough sample investigation could not be completed.Based on the investigation results, an exact cause for this incident could not be identified.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA SINGLE PORT
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key20649045
Report Number1710034-2024-01304
Device Sequence Number18382869
Product Code FOZ
UDI-Device Identifier00382903835201
UDI-Public(01)00382903835201(11)221108(17)251031(10)2312135
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Catalogue Number383520
Device Lot Number2312135
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/24/2024
Supplement Date Received by Manufacturer11/20/2024
Initial Report FDA Received Date11/10/2024
Supplement Report FDA Received Date12/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/08/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-